MRI-targeted or standard biopsy in prostate cancer screening M Eklund, F Jäderling, A Discacciati, M Bergman, M Annerstedt, M Aly, ... New England journal of medicine 385 (10), 908-920, 2021 | 271 | 2021 |
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non … T Nordström, A Discacciati, M Bergman, M Clements, M Aly, M Annerstedt, ... The Lancet Oncology 22 (9), 1240-1249, 2021 | 122 | 2021 |
Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005–2010: a population-based study from the national Swedish kidney cancer register A Thorstenson, M Bergman, AH Scherman-Plogell, S Hosseinnia, ... Scandinavian journal of urology 48 (3), 231-238, 2014 | 119 | 2014 |
No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial … J Lagercrantz, M Bergman, P Lundman, P Tornvall, P Hjemdahl, ... Blood coagulation & fibrinolysis 14 (8), 749-753, 2003 | 43 | 2003 |
Association between PSA density and prostate cancer in men without significant MRI lesions. A Mortezavi, M Eklund, M Bergman, SR Kjosavik, A Discacciati, ... BJU international 125 (6), 2020 | 9 | 2020 |
Identifying prostate cancer among men with lower urinary tract symptoms T Nordström, JC Engel, M Bergman, L Egevad, M Aly, M Eklund, ... European Urology Open Science 24, 11-16, 2021 | 4 | 2021 |
Improved prostate cancer diagnostics with a struc-tured pathway including the Stockholm3 test and MRI--targeted biopsies-experiences from Capio S: t Göran Prostate Cancer Center M Bergman, F Jäderling, E Meurling, A Thorstensson, T Nordström, ... Lakartidningen 115, FCDT-FCDT, 2018 | 4 | 2018 |
Prostate cancer screening using a combination of risk‐prediction, magnetic resonance imaging and targeted prostate biopsies: A randomised trial T Nordstrom, A Discacciati, M Bergman, M Clements, M Aly, M Annerstedt, ... Available at SSRN 3788918, 2021 | 2 | 2021 |
The Capio Prostate Cancer Center Model for Prostate Cancer Diagnostics—Real-world Evidence from 2018 to 2022 T Palsdottir, H Söderbäck, F Jäderling, M Bergman, H Vigneswaran, ... European Urology Open Science 61, 29-36, 2024 | 1 | 2024 |
The Capio Prostate Cancer Center model for prostate cancer diagnostics using Stockholm3, MRI, and targeted biopsies: Real-world evidence from 2018 to 2022. T Palsdottir, H Söderbäck, F Jäderling, M Bergman, HT Vigneswaran, ... Journal of Clinical Oncology 42 (4_suppl), 295-295, 2024 | | 2024 |
265P The Capio Prostate Cancer Center model for prostate cancer diagnostics using Stockholm3, MRI and targeted biopsies: Real-world evidence from 2018 to 2022 H Vigneswaran, H Söderbäck, F Jäderling, M Bergman, H Grönberg, ... Annals of Oncology 34, S1577, 2023 | | 2023 |
Improved prostate cancer diagnostics with a structured pathway including» Stockholm 3 «test, MRI and targeted perineal biopsies H Söderbäck, F Jäderling, F Wimmerkranz, J Andersson, M Bergman, ... Lakartidningen 120, 23077-23077, 2023 | | 2023 |
Re: MRI-Targeted or Standard Biopsy in Prostate Cancer Screening M Eklund, F Jaderling, A Discacciati, M Bergman, M Annerstedt, M Aly, ... JOURNAL OF UROLOGY 207 (1), 231-231, 2022 | | 2022 |
MRI-targeted or systematic biopsies in prostate cancer screening: The STHLM3MRI trial M Eklund, F Jäderling, A Discacciati, M Bergman, M Annerstedt, M Aly, ... European Urology 79, S1430, 2021 | | 2021 |
Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, magnetic resonance imaging and targeted prostate biopsies: The STHLM3MRI trial T Nordström, A Discacciati, M Bergman, M Aly, M Annerstedt, ... European Urology 79, S1429, 2021 | | 2021 |
Improved prostate cancer diagnostics with a structured pathway including the Stockholm3 test and MRI-targeted biopsies led by nurses A Thorstenson, C Melander-Bergstrom, C Cavalli-Bjorkman, M Bergman, ... SCANDINAVIAN JOURNAL OF UROLOGY 53, 40-40, 2019 | | 2019 |
Strukturerad kedja vid test för prostatacancer kortar ledtider H Söderbäck, F Jäderling, J Andersson, M Bergman | | |